Price
1D
5D
1M
6M
YTD
1Y
5Y
▤ Line ▾
⏱ 2m ▾
∿ Studies 0 ▾
⇄ Compare ▾
✎ Draw 0 ▾
EXT
%
LOG
⟲
⛶
Chart style ✕
Chart style
Line Area
Candles OHLC bars
Interval ✕
Interval
1 min 2 min
5 min 15 min
30 min 1 hour
1 day 1 week
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Studies ✕
Overlays
SMA 20 SMA 50
SMA 200 EMA 21
Bollinger VWAP
Session levels
Prior day H/L/C
Opening range
Volume profile
Lower pane
Volume
RSI 14 MACD
Compare ✕
Overlay another symbol
SPY QQQ
IWM DIA
Add
Remove comparison
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Drawing tools ✕
Tool
Cursor Trend line
Price level Zone
Measure
Clear all drawings
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Trailing performance Price return · vs SPY
Return vs SPY
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on GNNDY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals TTM · reported
Market cap —
Enterprise value —
Revenue (TTM) —
Gross profit —
EBITDA —
Net income —
EPS (TTM) —
Free cash flow —
Total cash —
Total debt —
Book value / share —
Shares outstanding —
Float —
Short % of float —
Dividend yield —
Beta (5Y) —
Valuation & profitability ratios Account required
Trailing P/E —
Forward P/E —
PEG ratio —
Price / sales —
Price / book —
EV / revenue —
EV / EBITDA —
Gross margin —
Operating margin —
Profit margin —
Return on equity —
Return on assets —
Debt / equity —
Current ratio —
Free account required
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements As reported · 5 years · 5 quarters
Income Balance sheet Cash flow
Annual Quarterly
Blank means not reported, not zero
Line item 2025 2024 2023 2022 YoY
Total revenue
$16.78B $17.98B $18.12B $18.69B
-6.7%
Operating revenue
$16.78B $17.98B $18.12B $18.69B
-6.7%
Cost of revenue
$7.63B $8.42B $9.18B $9.55B
-9.5%
Gross profit
$9.16B $9.56B $8.95B $9.13B
-4.3%
Research & development
$1.46B $1.49B $1.55B $1.41B
-2.1%
Selling, general & admin
$2.31B $2.44B $2.21B $6.15B
-5.4%
Total operating expense
$7.56B $7.78B $8.00B $8.01B
-2.8%
Operating income
$1.60B $1.79B $943.00M $1.12B
-10.6%
Net interest income
-$574.00M -$482.00M -$458.00M -$138.00M
-19.1%
Pre-tax income
$914.00M $1.36B $343.00M $725.00M
-32.8%
Tax provision
$204.00M $302.00M $77.00M $155.00M
-32.5%
Net income
$653.00M $988.00M $228.00M $511.00M
-33.9%
Net income to common
$653.00M $988.00M $228.00M $511.00M
-33.9%
Basic EPS
13.44 20.37 4.92 12.00
-34.0%
Diluted EPS
13.44 20.34 4.92 11.97
-33.9%
EBIT
$1.31B $1.74B $669.00M $911.00M
-24.7%
EBITDA
$2.65B $3.12B $2.40B $2.44B
-15.2%
Basic shares
48.54M 48.54M 46.29M 42.61M
0.0%
Diluted shares
48.57M 48.57M 46.33M 42.71M
0.0%
Line item 2025 2024 2023 2022 YoY
Cash & equivalents
$1.12B $980.00M $2.16B $990.00M
+14.2%
Cash & short-term investments
$1.12B $980.00M $2.16B $990.00M
+14.2%
Accounts receivable
$4.38B $4.67B $4.44B $4.03B
-6.2%
Inventory
$2.31B $2.58B $2.66B $3.52B
-10.5%
Total current assets
$8.64B $9.33B $10.18B $9.37B
-7.4%
Property, plant & equipment
$1.07B $1.09B $1.04B $1.25B
-1.9%
Goodwill & intangibles
$17.04B $17.32B $16.93B $17.55B
-1.6%
Total assets
$29.23B $30.61B $30.64B $30.59B
-4.5%
Total current liabilities
$7.32B $8.15B $15.64B $11.73B
-10.3%
Current debt
$1.82B $2.00B $9.67B $6.02B
-9.0%
Long-term debt
$8.56B $9.04B $3.53B $9.87B
-5.2%
Total debt
$10.81B $11.49B $13.50B $16.25B
-5.9%
Total liabilities
$18.33B $19.79B $21.05B $23.79B
-7.4%
Retained earnings
$14.27B $13.66B $12.78B $10.51B
+4.5%
Shareholder equity
$10.90B $10.82B $9.59B $6.80B
+0.7%
Working capital
$1.32B $1.18B -$5.46B -$2.37B
+12.5%
Net tangible assets
-$6.14B -$6.49B -$7.34B -$10.75B
+5.5%
Shares issued
150.91M 150.91M 150.91M 137.19M
-0.0%
Line item 2025 2024 2023 2022 2021 YoY
Net income
$1.60B $1.86B $869.00M $1.11B —
-14.2%
Depreciation & amortisation
$1.34B $1.38B $1.73B $1.53B —
-3.1%
Stock-based compensation
-$41.00M -$36.00M $18.00M $111.00M —
-13.9%
Change in working capital
$163.00M $176.00M $438.00M -$1.29B —
-7.4%
Operating cash flow
$2.68B $2.73B $2.64B $627.00M —
-1.8%
Capital expenditure
-$1.54B -$1.40B -$1.43B -$1.67B —
-9.6%
Investing cash flow
-$1.59B -$1.54B -$1.14B -$9.18B —
-3.0%
Share buybacks
— — — $0 -$1.17B
—
Dividends paid
-$85.00M — -$32.00M -$208.00M -$188.00M
—
Financing cash flow
-$886.00M -$2.37B -$312.00M $3.34B —
+62.5%
Free cash flow
$1.14B $1.32B $1.21B -$1.04B —
-13.9%
End cash position
$1.12B $980.00M $2.16B $990.00M —
+14.2%
Line item 2026-03-31 2025-12-31 2025-06-30 2025-03-31 2024-12-31 YoY
Total revenue
$2.10B $4.68B $4.16B $2.28B $5.02B
-55.2%
Operating revenue
$2.10B $4.68B $4.16B $2.28B $5.02B
-55.2%
Cost of revenue
$1.08B $2.18B $1.85B $1.13B $2.35B
-50.2%
Gross profit
$1.01B $2.50B $2.31B $1.16B $2.67B
-59.5%
Research & development
$617.00M $425.00M $344.00M $240.00M $355.00M
+45.2%
Selling, general & admin
$792.00M -$2.03B $1.42B $791.00M -$1.91B
+139.0%
Total operating expense
$1.48B $1.92B $1.85B $1.10B $2.08B
-22.6%
Operating income
-$472.00M $582.00M $461.00M $53.00M $597.00M
-181.1%
Net interest income
-$89.00M -$27.00M -$228.00M -$100.00M -$87.00M
-229.6%
Pre-tax income
-$561.00M $450.00M $232.00M -$47.00M $503.00M
-224.7%
Tax provision
-$124.00M $100.00M $52.00M -$10.00M $111.00M
-224.0%
Net income
-$955.00M $344.00M $165.00M $71.00M $367.00M
-377.6%
Net income to common
-$955.00M $344.00M $165.00M $71.00M $367.00M
-377.6%
Basic EPS
-19.68 — 3.39 1.47 —
—
Diluted EPS
-19.68 — 3.39 1.47 —
—
EBIT
-$373.00M $67.00M $529.00M $158.00M $549.00M
-656.7%
EBITDA
$1.21B $454.00M $807.00M $497.00M $875.00M
+165.6%
Basic shares
48.54M — 48.54M 48.54M —
—
Diluted shares
48.88M — 48.54M 48.54M —
—
Line item 2026-03-31 2025-12-31 2025-06-30 2025-03-31 2024-12-31 YoY
Cash & equivalents
$865.00M $1.12B $1.13B $787.00M $980.00M
-22.7%
Cash & short-term investments
$865.00M $1.12B $1.13B $787.00M $980.00M
-22.7%
Accounts receivable
$2.05B $4.38B $4.24B $4.28B $4.67B
-53.3%
Inventory
$1.55B $2.31B $2.40B $2.57B $2.58B
-33.0%
Total current assets
$18.27B $8.64B $8.99B $8.89B $9.33B
+111.5%
Property, plant & equipment
$212.00M $1.07B $1.01B $1.05B $1.09B
-80.1%
Goodwill & intangibles
$9.88B $17.04B $16.85B $17.13B $17.32B
-42.0%
Total assets
$28.55B $29.23B $29.49B $29.94B $30.61B
-2.3%
Total current liabilities
$9.13B $7.32B $7.89B $7.89B $8.15B
+24.8%
Current debt
$1.79B $1.82B $2.66B $2.56B $2.00B
-1.5%
Long-term debt
$8.03B $8.56B $8.71B $8.76B $9.04B
-6.2%
Total debt
$9.96B $10.81B $11.79B $11.77B $11.49B
-7.9%
Total liabilities
$18.43B $18.33B $19.04B $19.19B $19.79B
+0.6%
Retained earnings
$13.35B $14.27B $13.94B $13.73B $13.66B
-6.4%
Shareholder equity
$10.12B $10.90B $10.45B $10.75B $10.82B
-7.1%
Working capital
$9.14B $1.32B $1.11B $996.00M $1.18B
+590.5%
Net tangible assets
$237.00M -$6.14B -$6.40B -$6.37B -$6.49B
+103.9%
Shares issued
150.91M 150.91M 150.91M 150.91M 150.91M
0.0%
Line item 2026-03-31 2025-12-31 2025-06-30 2025-03-31 2024-12-31 YoY
Net income
-$1.09B $581.00M $460.00M $215.00M $601.00M
-287.3%
Depreciation & amortisation
$1.58B $387.00M $278.00M $339.00M $326.00M
+308.0%
Change in working capital
-$95.00M $314.00M $112.00M -$482.00M $7.00M
-130.3%
Operating cash flow
$339.00M $1.24B $650.00M -$43.00M $711.00M
-72.6%
Capital expenditure
-$361.00M -$500.00M -$341.00M -$286.00M -$549.00M
+27.8%
Investing cash flow
-$384.00M -$491.00M -$297.00M -$379.00M -$588.00M
+21.8%
Financing cash flow
-$118.00M -$389.00M $22.00M $242.00M -$247.00M
+69.7%
Free cash flow
-$22.00M $735.00M $309.00M -$329.00M $162.00M
-103.0%
End cash position
$956.00M $1.12B $1.13B $787.00M $980.00M
-14.6%
Analyst targets & ownership Account required
Mean target —
High target —
Low target —
Implied upside —
Analyst count —
Consensus —
Strong buy / Buy — / —
Hold —
Sell / Strong sell — / —
Held by insiders —
Held by institutions —
Institutions holding —
Free account required
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals Computed from 2Y daily closes
SMA 10
45.58
-4.34% from price
SMA 20
45.18
-2.59% from price
SMA 50
42.90
+2.60% from price
SMA 100
44.33
-1.64% from price
SMA 200
46.11
-4.56% from price
EMA 12
44.97
-3.05% from price
EMA 26
44.52
-2.06% from price
EMA 50
44.05
-1.02% from price
MACD (12,26,9)
0.45
Hist -0.37
ATR (14)
0.96
2.19% of price
Realised vol 30D
36.7%
Annualised
Bollinger upper
47.83
20, 2σ
Bollinger lower
42.52
20, 2σ
50 / 200 cross
Death
42.90 vs 46.11
Trend bias
Below 200
-4.56%
Options chain Account required
Expiry Loading…
Calls Puts
Spot 43.60
Calls Strike Last Bid Ask Vol OI IV
000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0%
Puts Strike Last Bid Ask Vol OI IV
000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0% 000.00 0.00 0.00 0.00 0 0 0.0%
Free account required
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile Daily returns · 1Y window
Beta vs SPY
-0.20
Less volatile than market
Correlation to SPY
-0.05
Largely independent
Realised vol 30D
36.7%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-30.5%
Peak to trough
Max drawdown 5Y
-84.2%
Peak to trough
Beta (reported)
—
5Y monthly, from filing
Headlines GNNDY · links out to the publisher
GN Store Nord AS (GGNDF) (Q2 2026) Earnings Call Highlights: Margin Guidance Upgraded Amid ...
GuruFocus.com · 4d ago
Interim Report Q2 2026: Successful reception of Evolve3 headsets and gross margin improvement boding well for strong H2 2026
GlobeNewswire · 5d ago
[Latest] Global Ear Health Market Size/Share Worth USD 16.87 Billion by 2035 at a 5.7% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire · 68d ago
Trading in GN Store Nord shares by board members, executives and associated persons
GlobeNewswire · 68d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.
Request the strategy overview